TOP 3 most risky and promising areas of biotech7 February 2018
Primer Capital’s Investment Project Manager Vitaly Kolobov shared his view on some of the things that a “non-profile” investor should keep in mind when investing in biotech.
In his column, Vitaly discusses different areas of biomedicine in terms of their investment potential. The tricky part is that the most promising areas are also the most risky ones.
Why is it ok to invest in almost all cardiology projects and not so ok to invest in blood pressure drugs, what aspects should alert the investor and what areas to choose if you are interested in an above-average profitability – find out
in Vitaly’s column in Vedomosti.